Sound Income Strategies’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $226K | Buy |
2,503
+1,613
| +181% | +$135K | 0.01% | 442 |
|
|
2026
Q1 | $72.3K | Buy |
890
+641
| +257% | +$52.8K | ﹤0.01% | 705 |
|
|
2025
Q4 | $21K | Buy |
249
+17
| +7% | +$1.4K | ﹤0.01% | 1137 |
|
|
2025
Q3 | $17.4K | Buy |
232
+68
| +41% | +$5.31K | ﹤0.01% | 845 |
|
|
2025
Q2 | $12.8K | Sell |
164
-9
| -5% | -$671 | ﹤0.01% | 871 |
|
|
2025
Q1 | $12.5K | Buy |
173
+144
| +497% | +$10.3K | ﹤0.01% | 844 |
|
|
2024
Q4 | $2.15K | Hold |
29
| – | – | ﹤0.01% | 1153 |
|
|
2024
Q3 | $1.91K | Hold |
29
| – | – | ﹤0.01% | 1137 |
|
|
2024
Q2 | $2.68K | Hold |
29
| – | – | ﹤0.01% | 1058 |
|
|
2024
Q1 | $2.77K | Hold |
29
| – | – | ﹤0.01% | 997 |
|
|
2023
Q4 | $2.21K | Hold |
29
| – | – | ﹤0.01% | 1044 |
|
|
2023
Q3 | $2.01K | Hold |
29
| – | – | ﹤0.01% | 907 |
|
|
2023
Q2 | $2.74K | Hold |
29
| – | – | ﹤0.01% | 842 |
|
|
2023
Q1 | $2.4K | Sell |
29
-32
| -52% | -$2.52K | ﹤0.01% | 812 |
|
|
2022
Q4 | $4.55K | Buy |
61
+41
| +205% | +$3.16K | ﹤0.01% | 660 |
|
|
2022
Q3 | $2K | Sell |
20
-153
| -88% | -$14.7K | ﹤0.01% | 696 |
|
|
2022
Q2 | $16K | Hold |
173
| – | – | ﹤0.01% | 381 |
|
|
2022
Q1 | $20K | Hold |
173
| – | – | ﹤0.01% | 350 |
|
|
2021
Q4 | $22K | Sell |
173
-60
| -26% | -$7K | ﹤0.01% | 348 |
|
|
2021
Q3 | $26K | Hold |
233
| – | – | ﹤0.01% | 306 |
|
|
2021
Q2 | $24K | Sell |
233
-147
| -39% | -$13.9K | ﹤0.01% | 315 |
|
|
2021
Q1 | $31.8K | Hold |
380
| – | – | 0.01% | 284 |
|
|
2020
Q4 | $35K | Buy |
380
+300
| +375% | +$24.9K | 0.01% | 242 |
|
|
2020
Q3 | $6K | Sell |
80
-430
| -84% | -$33.6K | ﹤0.01% | 507 |
|
|
2020
Q2 | $35K | Sell |
510
-450
| -47% | -$32K | 0.01% | 195 |
|
|
2020
Q1 | $60K | Hold |
960
| – | – | 0.02% | 113 |
|
|
2019
Q4 | $75K | Buy |
960
+900
| +1,500% | +$70.3K | 0.02% | 100 |
|
|
2019
Q3 | $4K | Hold |
60
| – | – | ﹤0.01% | 456 |
|
|
2019
Q2 | $4K | Hold |
60
| – | – | ﹤0.01% | 466 |
|
|
2019
Q1 | $4K | Sell |
60
-1,665
| -97% | -$95K | ﹤0.01% | 469 |
|
|
2018
Q4 | $88K | Hold |
1,725
| – | – | 0.05% | 90 |
|
|
2018
Q3 | $100K | Hold |
1,725
| – | – | 0.05% | 82 |
|
|
2018
Q2 | $84K | Hold |
1,725
| – | – | 0.05% | 77 |
|
|
2018
Q1 | $80K | Hold |
1,725
| – | – | 0.05% | 75 |
|
|
2017
Q4 | $73K | Buy |
+1,725
| New | +$63.3K | 0.05% | 74 |
|
Other funds holding EW
WT
Sound Income Strategies's EW Position: Q2 2026 in Review
Sound Income Strategies increased its Edwards Lifesciences (EW) stake by 181% in Q2 2026, buying an estimated $135K and bringing the position to 2,503 shares worth $226K. The position accounts for 0.01% of the portfolio, ranked #442.
Sound Income Strategies first reported a position in EW in Q4 2017 and has held it in 35 quarters since. 934 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Sound Income Strategies held 2,503 shares of Edwards Lifesciences worth $226K as of Q2 2026.
- Sound Income Strategies bought 1,613 Edwards Lifesciences shares in Q2 2026, an estimated $135K.
- Edwards Lifesciences made up 0.01% of Sound Income Strategies's portfolio in Q2 2026, its #442 holding.
- Sound Income Strategies first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 35 quarters since.
- 934 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.